Baxter's blood disorder drug gets FDA approval

(Reuters) - (This Oct. 24 story has been corrected to remove paragraph saying that Obizur will compete with Biogen Idec Inc's BIIB.O Eloctate. Eloctate is approved to treat congenital hemophilia A, not acquired hemophilia A)
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news